SUN PHARMACEUTICAL INDUSTRIES
|
|
| BOM : 524715 NSE : SUNPHARMA | |
| LT :
Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap] Debt : Low |
Updated: |
| ST :
Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
Jun 24,2022 |
|
Price(EOD): ₹ 824.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
| MCap: ₹ 197,726.31 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SUN PHARMACEUTICAL INDUSTRIES | 2.4% | -8.5% | 23.8% |
| DIVIS LABORATORIES | 4.3% | 6.7% | -12.6% |
| DR REDDYS LABORATORIES | 3.8% | 0% | -18.7% |
| CIPLA | 0.8% | -3.2% | -2.4% |
| GLAND PHARMA | 2.4% | -7.3% | -17.9% |
| PIRAMAL ENTERPRISES | 3.9% | -11% | -33.4% |
| CADILA HEALTHCARE | 5.7% | -5.1% | -45.1% |
| TORRENT PHARMACEUTICALS | 4.1% | -0.9% | -2.5% |
| ALKEM LABORATORIES | -3.6% | -0.7% | -3.5% |
FUNDAMENTAL ANALYSIS OF SUN PHARMACEUTICAL INDUSTRIES
[ Q(TTM): Mar2022, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF SUN PHARMACEUTICAL INDUSTRIES
[As on : Jun 24,2022
]
| Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
68.11
P/E Calculated based on EPS of 12.1
[ Mar2021 - Consolidated Results ] 4.26
P/B Calculated based on Book Value of 193.65
[ Mar2021 - Consolidated Results ] 5.12
P/S Calculated based on Revenues of 38654.5 Cr
[ TTM - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
3% -32% -35% |
SHARE PRICE MOMENTUM OF SUN PHARMACEUTICAL INDUSTRIES
SUN PHARMACEUTICAL INDUSTRIES vs SENSEX
DEBT OF SUN PHARMACEUTICAL INDUSTRIES
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2021 2020 2019 Avg_3yrs |
0.27 0.26 0.28 0.27 |
0.08 0.18 0.25 0.17 |
|
[Last Annual Data : Mar2021]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF SUN PHARMACEUTICAL INDUSTRIES
| Pledged Promoter Shares |
5.57 % | |
|---|---|---|
| As on : Mar2022 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF SUN PHARMACEUTICAL INDUSTRIES
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
-4.22% -16.38% -184.16% -204.3% |
10.84% 6.39% -329.85% -362.07% |
| QtrlyTrend |
-4 | |
| Latest Qtr: Mar2022 | ||
| Quarterly Result Analysis → | ||
SUN PHARMACEUTICAL INDUSTRIES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE 500 SHARIAH | 3.2% | -0.6% | -1.9% |
| S&P BSE HEALTHCARE | 3.1% | -1.8% | -13% |
| S&P BSE GREENEX | 3.1% | -3.5% | 1.5% |
| MFG | 2.8% | -2.7% | -1.3% |
| S&P BSE SENSEX | 2.7% | -1.9% | 0.3% |
| S&P BSE 100 ESG INDEX | 2.6% | -1.9% | 0.2% |
| S&P BSE SENSEX50 | 2.6% | -2% | -0.2% |
| S&P BSE LARGECAP | 2.6% | -2.2% | -0.4% |
| S&P BSE CARBONEX | 2.6% | -2.1% | -0.2% |
| S&P BSE 100 LARGECAP TMC | 2.6% | -2.1% | -0.7% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY HEALTHCARE | 3.3% | -1.7% | -11.6% |
| NIFTY PHARMA | 3.2% | -2.9% | -13.5% |
| NIFTY50 EQUAL WEIGHT | 3% | -2.4% | 0.1% |
| NIFTY GROWTH SECTOR 15 | 2.9% | -0.1% | 2.4% |
| NIFTY 100 EQUAL WEIGHT | 2.9% | -1.6% | -2.9% |
| NIFTY 100 | 2.7% | -2% | -0.8% |
| NIFTY 50 | 2.7% | -2% | -0.3% |
| NIFTY 200 | 2.6% | -2% | -0.9% |
| NIFTY 500 | 2.5% | -2% | -1% |
| NIFTY LARGE MIDCAP 250 | 2.4% | -1.7% | -0.8% |
You may also like the below Video Courses
FAQ about SUN PHARMACEUTICAL INDUSTRIES
Is SUN PHARMACEUTICAL INDUSTRIES good for long term investment?
As on Jun 24,2022, the Fundamentals of SUN PHARMACEUTICAL INDUSTRIES look Strong and hence it may be good for long term investment! See Financial Performance of SUN PHARMACEUTICAL INDUSTRIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is SUN PHARMACEUTICAL INDUSTRIES UnderValued or OverValued?
As on Jun 24,2022, SUN PHARMACEUTICAL INDUSTRIES is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES ?
As on Jun 24,2022, the Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES is Rs. 1,219.31 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 797.00
Fair Value [Median EV / Sales Model] : Rs. 1,219.31
Fair Value [Median Price / Sales Model] : Rs. 1,261.27
Median Fair Value of SUN PHARMACEUTICAL INDUSTRIES : Rs. 1,219.31
Is SUN PHARMACEUTICAL INDUSTRIES trading at a Premium or Discount?
As on Jun 24,2022, SUN PHARMACEUTICAL INDUSTRIES is trading at a Discount of -32% based on the estimates of Median Intrinsic Value!
Check out Annual Financials of Industry Peers
Check out Quarterly Results of Industry Peers
|
Quarterly Results of DIVIS LABORATORIES LTD Quarterly Results of DR REDDYS LABORATORIES LTD Quarterly Results of CIPLA LTD Quarterly Results of GLAND PHARMA LTD |
Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
|
Market Cap of DIVIS LABORATORIES LTD Market Cap of DR REDDYS LABORATORIES LTD Market Cap of CIPLA LTD Market Cap of GLAND PHARMA LTD |
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].
